the aid library

LIST OPTIONS

Filter

7119

Sort by:

Direction:

Download (85)

View PDF (1142)

Disparity between burden and budget for mental health

Saxena, S. (2019) CC

Published OnlineNovember 13, 2018 http://dx.doi.org/10.1016/ S2468-2667(18)30238-X

Download (213)

View PDF (250)

Findings from othe Global Burden of Disease Study 2017

Institute for Health Metrics and Evaluation (IHME), The Lancet (2019) CC

This booklet provides an overview of all findings from the Global Burden of Disease 2017 study. Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, repli... more

Download (133)

View PDF (1830)

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Stroke Collaborators (2019) CC

Lancet Neurol. Volume 18, ISSUE 5, P439-458, May 01, 2019 Published Mar 11. pii: S1474-4422(19)30034-1. doi: 10.1016/S1474-4422(19)30034-1.

Download (122)

View PDF (1342)

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Neurology Collaborators (2019) CC

Lancet Neurol 2019 Volume 18, ISSUE 5, P459-480, May 01, 2019 Published OnlineMarch 14, 2019 http://dx.doi.org/10.1016/ S1474-4422(18)30499-X

Download (142)

View PDF (1461)

Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Epilepsy Collaborators (2019) CC

Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. Epub 2019 Feb 14.

Download (66)

View PDF (710)

Mortality due to road injuries in the states of India: the Global Burden of Disease Study 1990–2017

India State-Level Disease Burden Initiative Road Injury Collaborators (2019) CC

Lancet Public Health. 2019 Dec 20. pii: S2468-2667(19)30246-4. doi: 10.1016/S2468-2667(19)30246-4.

Download (130)

View PDF (168)

Global report on the epidemiology and burden of sepsis: Current evidence, identifying gaps and future directions

World Health Organisation (2020) CC

Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.

Download (65)

View PDF (1232)

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

COVID-19 Mental Disorders Collaborators (2021) CC

The Lancet Published Online October 8, 2021 https://doi.org/10.1016/ S0140-6736(21)02143-7

Download (75)

View PDF (653)

Global, regional, and national burden of mortality associated with non-optimal ambient temperatures from 2000 to 2019: a three-stage modelling study

Zhao,Q.; Guo Y., , Ye T., et al. (2021) C1

Lancet Planet Health 2021; 5: e415–25

Download (99)

View PDF (448)

Increasing tuberculosis burden in Latin America: an alarming trend for global control efforts

O. T. Ranzani; Pescarini, J. M.; Martinez, L.; et. al. BMJ Global Health (2021) CC

The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden countries. T o illustrate the recent increase in TB incidence in the region, we selected 12 countries from Latin America (Argentina, Brazil, Chile, Colombia, Ecuador, El Salvador... more

Download (78)

View PDF (143)

The Geographical Distribution and Burden of Trachoma in Africa

Smith, J.; Flueckiger, P.; Hopper, J. Public Library of Science PLOS (2013) CC

In order to target resources and drugs to reach trachoma elimination targets by the year 2020, data on the burden of disease are required. Using prevalence data in African countries derived from the Global Atlas of Trachoma (GAT), the distribution of trachoma continues to be focused in East and West... more

Download (90)

View PDF (400)

A toolkit for national dengue burden estimation

Brady, O. J. et all. WHO (2018) CC

The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden of dengue.

Download (86)

View PDF (441)

The global burden of chromoblastomycosis

Santos, D.; Pedrozo e Silva de Azevedo, C.; Aparecida Vincent, V. et al. (2021) CC

Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.

Download (86)

View PDF (221)

Global snakebite burden Report by the Director-General

World Health Organization WHO (2018) C_WHO

Snakebite envenoming is a potentially life-threatening disease that typically results from the injection of a mixture of different toxins (“venom”) following the bite of a venomous snake. Envenoming can also be caused by venom being sprayed into a person’s eyes by certain species of snakes tha... more

Download (27)

View PDF (12)

Diabetes Disease Burden - Countries Profiles 2023 PAHO

Pan American Health Organization PAHO (2023) C_WHO

Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resist... more

Download (24)

View PDF (30)

Global, regional, and national burden of chronic obstructive pulmonary disease from 1990 to 2019

Wang, H.; Ye, X.; Zhang, Y.; Ling, S.; Frontiers in Physiology (2022) CC2

We aimed to estimate the incidence, mortality, disability-adjusted life years (DALYs) for chronic obstructive pulmonary disease (COPD) in 204 countries and territories. We examined the variations in these trends by country, gender, age group, and sociodemographic index (SDI).

Download (30)

View PDF (24)

Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Asher, I.; Rutter, C.E.; Bissell, K. et al. The Lancet (2021) CC

Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing. This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Chi...ldhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders. Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries. Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma. more

Download (48)

View PDF (63)

The increasing burden of asthma in South African children: A call to action

Masekela, R.; Gray, C.L.; Green, R.J. et al. The South African Medical Journal (2018) CC

BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is increasing in low- and middle-income countries and remains under-recognised and poorly managed. OBJE... more

Download (11)

View PDF (20)

The global burden of asthma: executive summary of the GINA Dissemination Committee report

Masoli, M.; Fabian, D.; Holt, S.; Beasley, R. European Journal of allergy and clinical immunology: Volume59, Issue5 May 2004 Pages 469-478 (2004) CC2

It is estimated that as many as 300 million people of all ages, and all ethnic backgrounds, suffer from asthma and the burden of this disease to governments, health care systems, families, and patients is increasing worldwide. In 1989 the Global Initiative for Asthma (GINA) program was initiated in ... more

Download (23)

View PDF (9)

Tuberculosis profile: Malawi; Estimates of TB burden*, 2022

World Health Organization WHO (2022) C_WHO

Estimates of TB burden